المؤلفون: Bitterman A; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York., Martins CP; Albert Einstein College of Medicine, Bronx, New York., Cices A; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York., Nadendla MP; University of Denver, Denver, Colorado.

المصدر: JAMA network open [JAMA Netw Open] 2022 Mar 01; Vol. 5 (3), pp. e223079. Date of Electronic Publication: 2022 Mar 01.

نوع المنشور: Comparative Study; Journal Article; Meta-Analysis; Systematic Review

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Endemic Diseases* , COVID-19 Drug Treatment*, Antiparasitic Agents/*therapeutic use , Antiviral Agents/*therapeutic use , COVID-19/*mortality , Ivermectin/*therapeutic use , Strongyloidiasis/*epidemiology, Humans ; Prevalence ; Randomized Controlled Trials as Topic ; Risk ; Strongyloidiasis/drug therapy